ATC Φάρμακα Δραστικές ICPC2 ICD10 Ιατρική στην Πράξη Νοσήματα Λοιμώξεις Εμβόλια Πρωτόκολλα
  • Lucanthone
  • indication:Intended for use as a radiation sensitizer in the treatment of brain cancer.
  • pharmacologypharmacology:
  • mechanism: Recent data suggests that lucanthone inhibits post-radiation DNA repair in tumor cells. The ability of lucanthone to inhibit AP endonuclease and topoisomerase II probably account for the specific DNA repair inhibition in irradiated cells.
  • toxicity:
  • absorprion: Orally available
  • halflife:
  • roouteelimination:
  • volumedistribution:
  • clearance: